Ascentage Pharma Group International

NASDAQ:AAPG

Biotechnology

Healthcare
$12.44 +1.78%

+$0.31 today

Market cap
$1.16B
Beta
0.65
P/E (TTM)
-8.9
EPS (TTM)
-$13.29
52W Low $16.92High $48.45

Volume 0.00M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$3.97B

FY 2025 · Annual

+51.5% YoY

Liabilities

$2.63B

FY 2025 · Annual

+12.3% YoY

Equity

$1.34B

FY 2025 · Annual

+387.0% YoY

Balance Sheet

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.71B1.48B1.07B1.24B2.47B
Short-term Investments00000
Net Receivables54.13M61.49M163.54M99.07M253.1M
Inventory3.93M9.45M16.17M6.6M28.64M
Other Current Assets59.26M16.6M24.54M24.63M192.65M
Total Current Assets1.89B1.64B1.34B1.47B2.95B
Property, Plant & Equipment (Net)854.3M650.03M957.23M905.86M829.59M
Goodwill24.69M24.69M24.69M24.69M24.71M
Intangible Assets60.41M84.3M85.45M76M65.98M
Long-term Investments27.85M18.53M18.95M33.86M37.05M
Tax Assets51.65M54.29M59.84M44.24M31.98M
Other Non-current Assets35.88M361.93M10.05M59M30.74M
Total Non-current Assets1.05B1.19B1.16B1.14B1.02B
Total Assets2.94B2.83B2.5B2.62B3.97B
Account Payables70.86M95.56M72.45M91.97M106.81M
Short-term Debt39.8M510.31M606.65M769.62M1.22B
Tax Payables3.28M7.18M8.39M9.63M0
Deferred Revenue024.35M38.41M54.09M37.51M
Other Current Liabilities58.73M2.82M00276.84M
Total Current Liabilities361.11M881.15M934.17M1.17B1.64B
Long-term Debt1.03B1.27B1.17B868.64M742.8M
Deferred Tax Liabilities13.75M12.15M10.55M5.37M0
Deferred Revenue (Non-current)243.28M218.63M287.55M275.96M216.86M
Other Non-current Liabilities52.34M35.33M18.3M6.27M12.04M
Total Non-current Liabilities1.34B1.54B1.5B1.18B986.62M
Total Liabilities1.71B2.42B2.43B2.34B2.63B
Common Stock178K180K197K214K256.16K
Retained Earnings(3.56B)(4.44B)(5.37B)(5.77B)0
Accumulated OCI(550.95M)(518.51M)(504.46M)(510.59M)1.33B
Other Stockholders Equity00000
Minority Interest0010.22M9.97M9.76M
Total Equity1.23B408.66M70.63M274.16M1.34B
Total Debt1.08B1.79B1.8B1.67B1.98B
Net Debt(622.6M)317.09M726.3M431.92M(490.68M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$2.5B
Receivables$253.1M
Inventory$28.6M
Other Current$192.7M
Total Current Assets$2.9B
PP&E (Net)$829.6M
Goodwill$24.7M
Intangible Assets$66.0M
Long-term Investments$37.1M
Tax Assets$32.0M
Other Non-current$30.7M
Total Non-current Assets$1.0B
Total Assets$4.0B

Analysis

Selected assets total $4.0B for Latest. The largest visible component is Cash & Equivalents at $2.5B, about 62.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
6-K6-K filingOct 28, 2026
6-K6-K filingOct 22, 2026
6-K6-K filingOct 21, 2026
6-K6-K filingOct 15, 2026

How much cash does AAPG have?

Ascentage Pharma Group International (AAPG) reported $2.47B in cash and equivalents in fiscal 2025.

How much debt does AAPG carry?

Ascentage Pharma Group International (AAPG) reported $1.98B of total debt, with net debt of -$490.68M.